Zimmer Biomet Holdings ZBH
NYSE ZBH
$94.61 +0.39 (+0.41%)
As of: Sep 9, 2026 · 3:59 PM EDT

Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026)

Zimmer Biomet Holdings (ZBH) posted Non-Current Assets of $17.7 billion for Q2 2026, little changed on a QoQ basis from $17.8 billion in Q1 2026, and down 0.62% year-over-year from $17.8 billion in Q2 2025.

Analysis

Zimmer Biomet Holdings (ZBH) Non-Current Assets (2009 - 2026) Analysis & Trends

Zimmer Biomet Holdings has reported Non-Current Assets for 18 years, with the latest figure at $17.7 billion in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 0.62% year-over-year to $17.7 billion in Q2 2026; TTM through Jun 2026 was $71.1 billion, a 4.61% increase from a year earlier, with the FY2025 full-year figure at $18.0 billion, up 7.66% from the prior year.
  • Non-Current Assets was $17.7 billion for Q2 2026 at Zimmer Biomet Holdings, roughly flat from $17.8 billion in the prior quarter.
  • The five-year high for Non-Current Assets was $18.0 billion in Q4 2025, with the low at $16.6 billion in Q1 2025.
  • Average Non-Current Assets over 5 years is $17.1 billion, with a median of $16.9 billion recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets retreated 10.41% in 2022, then gained 7.66% in 2025.
  • Over 5 years, Non-Current Assets stood at $16.6 billion in 2022, then grew by 1.49% to $16.9 billion in 2023, then dropped by 1.15% to $16.7 billion in 2024, then increased by 7.66% to $18.0 billion in 2025, then slipped by 1.51% to $17.7 billion in 2026.
  • The last three Non-Current Assets figures came in at $17.7 billion (Q2 2026), $17.8 billion (Q1 2026), and $18.0 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 84.70 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 11.33 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 68.92 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 33.51 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 37.24 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 7.05 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn 24.47 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 2.37 Bn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 8.29 Bn
10 Zimmer Biomet Holdings 18.20 Bn 17.79 Bn 1.54 Bn 17.70 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.70 Bn
Mar 31, 2026 17.76 Bn
Dec 31, 2025 17.97 Bn
Sep 30, 2025 17.65 Bn
Jun 30, 2025 17.81 Bn
Mar 31, 2025 16.59 Bn
Dec 31, 2024 16.69 Bn
Sep 30, 2024 16.86 Bn
Jun 30, 2024 16.88 Bn
Mar 31, 2024 16.82 Bn
Dec 31, 2023 16.89 Bn
Sep 30, 2023 16.85 Bn
Jun 30, 2023 16.91 Bn
Mar 31, 2023 16.83 Bn
Dec 31, 2022 16.64 Bn
Sep 30, 2022 16.80 Bn
Jun 30, 2022 16.99 Bn
Mar 31, 2022 17.10 Bn
Dec 31, 2021 18.57 Bn
Sep 30, 2021 18.70 Bn